Global Viral Detection Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Viral Detection Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Plaque Assays
  • 1.4.3 PCR
  • 1.4.4 ELISA
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Viral Detection Market Share by Application (2014-2025)
  • 1.5.2 Blood & Blood Products
  • 1.5.3 Cellular & Gene Therapy Products
  • 1.5.4 Stem Cell Products
  • 1.5.5 Tissue & Tissue Products
  • 1.5.6 Vaccines and Therapeutics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Viral Detection Market Size
• 2.2 Viral Detection Growth Trends by Regions
  • 2.2.1 Viral Detection Market Size by Regions (2014-2025)
  • 2.2.2 Viral Detection Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Viral Detection Market Size by Manufacturers
  • 3.1.1 Global Viral Detection Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Viral Detection Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
• 3.2 Viral Detection Key Players Head office and Area Served
• 3.3 Key Players Viral Detection Product/Solution/Service
• 3.4 Date of Enter into Viral Detection Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Viral Detection Market Size by Type (2014-2019)
• 4.2 Global Viral Detection Market Size by Application (2014-2019)

5 United States

• 5.1 United States Viral Detection Market Size (2014-2019)
• 5.2 Viral Detection Key Players in United States
• 5.3 United States Viral Detection Market Size by Type
• 5.4 United States Viral Detection Market Size by Application

6 Europe

• 6.1 Europe Viral Detection Market Size (2014-2019)
• 6.2 Viral Detection Key Players in Europe
• 6.3 Europe Viral Detection Market Size by Type
• 6.4 Europe Viral Detection Market Size by Application

7 China

• 7.1 China Viral Detection Market Size (2014-2019)
• 7.2 Viral Detection Key Players in China
• 7.3 China Viral Detection Market Size by Type
• 7.4 China Viral Detection Market Size by Application

8 Japan

• 8.1 Japan Viral Detection Market Size (2014-2019)
• 8.2 Viral Detection Key Players in Japan
• 8.3 Japan Viral Detection Market Size by Type
• 8.4 Japan Viral Detection Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Viral Detection Market Size (2014-2019)
• 9.2 Viral Detection Key Players in Southeast Asia
• 9.3 Southeast Asia Viral Detection Market Size by Type
• 9.4 Southeast Asia Viral Detection Market Size by Application

10 India

• 10.1 India Viral Detection Market Size (2014-2019)
• 10.2 Viral Detection Key Players in India
• 10.3 India Viral Detection Market Size by Type
• 10.4 India Viral Detection Market Size by Application

11 Central & South America

• 11.1 Central & South America Viral Detection Market Size (2014-2019)
• 11.2 Viral Detection Key Players in Central & South America
• 11.3 Central & South America Viral Detection Market Size by Type
• 11.4 Central & South America Viral Detection Market Size by Application

12 International Players Profiles

• 12.1 Avance Biosciences Inc. (U.S.)
  • 12.1.1 Avance Biosciences Inc. (U.S.) Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Viral Detection Introduction
  • 12.1.4 Avance Biosciences Inc. (U.S.) Revenue in Viral Detection Business (2014-2019)
  • 12.1.5 Avance Biosciences Inc. (U.S.) Recent Development
• 12.2 BSL BIOSERVICE (Germany)
  • 12.2.1 BSL BIOSERVICE (Germany) Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Viral Detection Introduction
  • 12.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2014-2019)
  • 12.2.5 BSL BIOSERVICE (Germany) Recent Development
• 12.3 Clean Cells (France)
  • 12.3.1 Clean Cells (France) Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Viral Detection Introduction
  • 12.3.4 Clean Cells (France) Revenue in Viral Detection Business (2014-2019)
  • 12.3.5 Clean Cells (France) Recent Development
• 12.4 Charles River Laboratories International, Inc. (U.S.)
  • 12.4.1 Charles River Laboratories International, Inc. (U.S.) Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Viral Detection Introduction
  • 12.4.4 Charles River Laboratories International, Inc. (U.S.) Revenue in Viral Detection Business (2014-2019)
  • 12.4.5 Charles River Laboratories International, Inc. (U.S.) Recent Development
• 12.5 Lonza Group (Switzerland)
  • 12.5.1 Lonza Group (Switzerland) Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Viral Detection Introduction
  • 12.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2014-2019)
  • 12.5.5 Lonza Group (Switzerland) Recent Development
• 12.6 Merck KGaA (Germany)
  • 12.6.1 Merck KGaA (Germany) Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Viral Detection Introduction
  • 12.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2014-2019)
  • 12.6.5 Merck KGaA (Germany) Recent Development
• 12.7 Sigma-Aldrich Corporation (U.S.)
  • 12.7.1 Sigma-Aldrich Corporation (U.S.) Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Viral Detection Introduction
  • 12.7.4 Sigma-Aldrich Corporation (U.S.) Revenue in Viral Detection Business (2014-2019)
  • 12.7.5 Sigma-Aldrich Corporation (U.S.) Recent Development
• 12.8 SGS S.A. (Switzerland)
  • 12.8.1 SGS S.A. (Switzerland) Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Viral Detection Introduction
  • 12.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2014-2019)
  • 12.8.5 SGS S.A. (Switzerland) Recent Development
• 12.9 Texcell, Inc. (France)
  • 12.9.1 Texcell, Inc. (France) Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Viral Detection Introduction
  • 12.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2014-2019)
  • 12.9.5 Texcell, Inc. (France) Recent Development
• 12.10 WuXi PharmaTech (Cayman) Inc. (China)
  • 12.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Viral Detection Introduction
  • 12.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2014-2019)
  • 12.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer